
    
      This is a randomized controlled non-inferiority designed trial.

      Follow up:

      Patients will stop their anti-arrhythmic drugs 2 months post procedure. Follow-ups will
      involve clinical assessment, holter and/or loop recorders at 3, 6, 9, and 12 month intervals.
    
  